The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.

President Donald Trump sent letters to 17 pharmaceutical CEOs demanding lower drug prices within 60 days, following an executive order signed earlier this year. According to the letter, the order is ...